US President Donald Trump continues to move forward with easing federal regulations on the use of cannabis. He signed a decree on the basis of which the plant and the component cannabidiol (CBD) will be classified in a lower drug category in the future. The order directs the Justice Department to initiate the reclassification.
“There are people who are begging me to do this, people who have been in great pain for decades,” Trump said. With this step, he is implementing an initiative by the previous government under former President Joe Biden. However, the proposal still requires approval from the anti-drug agency DEA.
Many US states have banned personal consumption of Marijuana already legalized for adults or allow it for medical purposes. At the federal level, the laws are still stricter. Users can still be prosecuted with the new rating. It is “not a decriminalization”. marijuanasaid Trump.
Republicans are critical of easing measures
Marijuana is currently listed as a drug in the first category in the USA. This is where the US anti-drug agency DEA locates those drugs, substances and chemicals that have no recognized medical use and a high potential for abuse.
In the future, marijuana will belong to the third category. This includes active ingredients with a moderate to low potential for physical and psychological dependence. These include, among others, ketamine, anabolic steroids and testosterone.
More than 20 Republican senators wrote a letter to Trump this year urging him to keep marijuana in the current drug category. The means is still dangerousthey argued. In addition, the use of the drug has negative effects on physical and mental health as well as safety on the roads and at work.
